Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SURMODICS INC (SRDX)
|
Add to portfolio |
|
|
|
| Price: |
$49.72
| | Metrics |
| OS: |
14.1
|
M
| |
|
|
| Market cap: |
$702
|
M
| |
-77
|
% ROIC
|
|
Net cash:
|
$26.4
|
M
| |
$1.87
|
per share
|
|
EV:
|
$676
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($28.4)
|
M
| |
|
|
| EPS |
($2.02)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-22 | Sep-05-22 | Sep-30-21 | Sep-05-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 |
| Revenues | 100.0 | 100.0 | 105.1 | 105.1 | 94.9 | 100.1 | 81.3 | 73.1 |
| Revenue growth | -4.9% | -4.9% | 10.8% | | -5.2% | 23.0% | 11.2% | 2.4% |
| Cost of goods sold | 20.3 | 20.3 | 17.2 | 17.2 | 15.3 | 13.6 | 14.0 | 11.4 |
| Gross profit | 79.6 | 79.6 | 88.0 | 88.0 | 79.5 | 86.4 | 67.3 | 61.7 |
| Gross margin | 79.6% | 79.6% | 83.7% | 83.7% | 83.9% | 86.4% | 82.8% | 84.4% |
| Selling, general and administrative | 50.6 | 46.9 | 46.7 | 30.7 | 50.2 | 24.0 | 24.1 | 20.5 |
| Research and development | 50.6 | | 46.7 | | 50.2 | 52.9 | 41.0 | 31.8 |
| EBITA | -17.8 | -22.1 | 9.6 | 6.7 | 1.1 | 10.0 | 1.8 | 9.7 |
| EBITA margin | -17.8% | -22.1% | 9.2% | 6.4% | 1.1% | 10.0% | 2.2% | 13.3% |
| Amortization of intangibles | 4.4 | | 3.1 | | 2.5 | 2.6 | 2.7 | 2.6 |
| EBIT | -22.2 | -22.1 | 6.5 | 6.7 | -1.4 | 7.4 | -0.9 | 7.1 |
| EBIT margin | -22.2% | -22.1% | 6.2% | 6.4% | -1.5% | 7.4% | -1.1% | 9.7% |
| Pre-tax income | -22.5 | -22.5 | 6.3 | 6.3 | -1.5 | 7.6 | -7.5 | 7.0 |
| Income taxes | 4.8 | 4.8 | 2.1 | 2.1 | -2.6 | 0.0 | -3.1 | 3.1 |
| Tax rate | | | 33.2% | 33.2% | 177.2% | | 40.8% | 44.2% |
| Net income | -27.3 | 0.0 | 4.2 | 0.0 | 1.1 | 7.6 | -4.5 | 3.9 |
| Net margin | -27.3% | 0.0% | 4.0% | 0.0% | 1.2% | 7.6% | -5.5% | 5.4% |
| |
| Diluted EPS | ($1.96) | $0.00 | $0.30 | $0.00 | $0.08 | $0.55 | ($0.34) | $0.29 |
| Shares outstanding (diluted) | 13.9 | 13.9 | 14.0 | 13.8 | 13.8 | 13.8 | 13.2 | 13.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|